Selective Targeting of Boronophenylalanine to Melanoma in BALB/c Mice for Neutron Capture Therapy

Cancer Research

Volumn 47, Issue 23, 1987, Pages 6377-6383

  Fand, Irwin ^c   Cohen, Scott ^c   Fairchild, Ralph G ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b Department of Physiology and Biophysics ^*  (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE;

ANIMAL EXPERIMENT; DRUG TARGETING; MELANOMA; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN;

ANIMAL; BORON COMPOUNDS; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANINS; MELANOMA; MICE; MICE, INBRED BALB C; NEUTRONS; PHENYLALANINE; STEREOISOMERISM; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0023489895     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Taylor, H. T., and Goldhaber, M. Detection of nuclear disintegration in a photographic emulsion. Nature (Lond.), 135: 341, 1935.
2. Gabel, D., Fairchild, R. G., Borner, H. G., and Larsson, B. The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reaction in boron and nitrogen. Radiat. Res., 98: 307–316, 1984.
3. Sweet, W. H. Practical problems in the past in the use of boron-slow neutron capture therapy in the treatment of glioblastoma multiforme. Proceedings of First International Symposium on Neutron Capture Therapy. Brookhaven National Laboratory Report No. 51730, pp. 376–378, 1983.
4. Hatanaka, H. Clinical experience of boron neutron capture therapy for gliomas—a comparison with conventional chemo-immuno-radiotherapy. In: H. Hatanaka (ed.), Boron Neutron Capture Therapy for Tumors, pp. 349–379. Niigata, Japan: Nishimura Co., Ltd., 1986.
5. Sweet, W. H. Medical aspects of boron slow neutron capture therapy. In: R. G. Fairchild and V. P. Bond (eds.), Workshop on Neutron Capture Therapy, Brookhaven National Laboratory, Report No. 51994, pp. 3–21, 1986.
6. Mishima, Y., Ichihashi, M., Tsuji, M., Ueda, M., Hatta, S., Nakagawa, T., Tanaka, C., and Taniyama, K. Prerequisities of first clinical trial for melanoma selective thermal neutron capture therapy. In: H. Hatanaka (ed.), Neutron Capture Therapy, Proceedings of the Second International Symposium on Neutron Capture Therapy, pp. 230–236. Niigata, Japan: Nishimura Co., Ltd., 1986.
7. Fairchild, R. G., and Bond, V. P. Current status of 10B neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int. J. Radiat. Oncol. Biol. Phys., 11: 831-840, 1985.
8. Snyder, H. R., Reedy, A. J., and Lennarz, W. Synthesis of aromatic boronic acids. Aldehydo boronic acids and a boronic acid analog of tyrosine. J. Am. Chem. Soc., 80: 835-838, 1958.
9. Bean, F. R., and Johnson, J. R. Derivatives of phenylboric acid, their preparation and action upon bacteria. II. Hydroxyphenylboric acids. J. Am. Chem. Soc., 54: 4415-4421, 1932.
10. Roberts, D. C., Suda, K., Samanen, J., and Kemp, D. S. Pluripotential amino acids I. (L)-p-Dihydroxyborylphenylalanine (L-Bph) as a precursor of L-Phe and L-Tyr containing peptides; specific tritiation of L-Phe-containing peptides as a final step in synthesis. Tetrahedron Lett., 21: 3435-3438, 1980.
11. Tong, J. H., Petticlerc, C., D'lorio, A., and Benoiton, N. L. Resolution of ring-substituted phenylalanines by the action of α-chymotrypsin on their ethyl esters. Can. J. Biochem., 49: 877-881, 1971.
12. Glass, J. D. p-Borono-L-phenylalanine. Proceedings of First International Symposium on Neutron Capture Therapy, Brookhaven National Laboratory Report No. 51730, pp. 255–259, 1983.
13. Fairchild, R. G., Packer, S., Greenberg, D., Som, P., Brill, A. B., Fand, I., and McNally, W. P. Thiouracil distribution in mice carrying transplantable melanoma. Cancer Res., 42: 5126–5132, 1982.
14. Watts, K. P., Fairchild, R. G., Slatkin, D., Greenberg, D., Packer, S., Atkins, H. L., and Hannon, S. J. Melanin content of hamster tissues, human tissues and various melanomas. Cancer Res., 41: 467-472, 1981.
15. Fairchild, R. G., Gabel, D., Laster, B. H., Greenberg, D., Kiszenick, W., and Micca, P. Microanalytical techniques for boron analysis using the l0B(n, α)7Li reaction. Med. Phys., 13: 50–56, 1986.
16. Larsson, B., Gabel, D., and Borner, H. G. Boron-loaded macromolecules in experimental physiology: tracing by neutron capture radiography. Phys. Med. Biol., 29: 361–370, 1984.
17. Abe, M., Kazuyoski, A., Kitamura, K., Tateishi, J., and Hatanaka, H. Boron distribution analysis by alpha-autoradiography. J. Nucl. Med., 27: 677-684, 1986.
18. Gabel, D., Holstein, H., Larsson, B., Gille, L., Eriksson, G., Sacker, D., Som, P., and Fairchild, R. G. Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron-containing compounds. Cancer Res. 47: 5451–5454, 1987.
19. Fand, I., Sharkey, R. M., Primus, F. J., Cohen, S., and Goldenburg, D. M. Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiography. Cancer Res. 47: 2177–2183, 1987.
20. Soloway, A. H., Wright, R. L., and Messer, J. R. Evaluation of boron compounds for use in neutron capture therapy of brain tumors. I. Animal investigations. J. Pharmacol Exp. Ther., 134: 117–122, 1961.
21. Ichihashi, M., Nakanishi, T., and Mishima, Y. Specific killing effect of 10B1-paraboronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation. J. Invest. Dermatol., 78: 215-218, 1982.
22. Ichihashi, M., Mishima, Y., Ueda, M., Hayashibe, K., Hatta, S., Funasaka, Y., and Fujiwara, H. Selective lethal effects of l0B1-paraboronophenylalanine on mouse and human melanoma cells in thermal neutron capture therapy enhanced by tyrosine and phenylalanine deficiency. In: H. Hatanaka (ed.), Neutron Capture Therapy, Proceedings of the Second International Symposium on Neutron Capture Therapy, pp. 237–242, Niigata, Japan: Nishimura Co., Ltd., 1986.
23. Utsumi, H., Ichihashi, M., Funasaka, Y., Mishima, Y., Ikushima, T., Kobayashi, T., and Kanda, K. Potentially lethal damage repair of B-16 melanoma cells pre-treated with 10B1-paraboronophenylalanine after exposure to thermal neutron radiation. H. Hatanaka (ed.), Neutron Capture Therapy, pp. 247–257. Niigata, Japan: Nishimura Co., Ltd, 1986.
24. Mishima, Y., Ichihashi, M., Nakanishi, T., Tsiyi, M., Ueda, M., Nakagawa, T., and Suzuki, T. Cure of malignant melanoma by single thermal neutron capture treatment using melanoma-seeking compounds. Proceedings of First International Symposium on Neutron Capture Therapy. Brookhaven National Laboratory Report No. 51730, pp. 355–364, 1983.
25. Hiratsuka, J., Kimura, S., and Mishima, Y. RBE of thermal neutron capture therapy of malignant melanoma using 10B1-paraboronophenylalanine in comparison with 9 MeV electron beam irradiation. In: H. Hatanaka (ed.), Neutron Capture Therapy, Proceedings of the Second International Symposium on Neutron Capture Therapy, pp. 281–286, Niigata, Japan: Nishimura Co., Ltd., 1986.
26. Hatta, S., Tsuji, M., Honda, C., Ichihashi, M., and Mishima, Y. Selective Affinity of l0B1-paraboronophenylalanine HC1 to malignant melanoma: in relation to thermal neutron capture therapy. H. Hatanaka (ed.), Neutron Capture Therapy, pp. 303–305. Niigata, Japan: Nishimura Co., Ltd., 1986.
27. Slatkin, D., Micca, P., Forman, A., Gabel, D., Wielopolski, L., and Fairchild, R. Boron uptake in melanoma, cerebrum and blood from Na2B12H11SH and Na4B24H22S2 administered to mice. Biochem. Pharmacol., 35: 1771–1776, 1986.
28. Moustafa, H. F., and Hopewell, J. W. Late functional changes in the vasculature of the rat brain after local x-irradiation. Br. J. Radiol., 53: 21–25, 1980.